Skip to main content
Clinical Trials/TCTR20180419004
TCTR20180419004
Completed
Phase 4

Effect of the Robotic-assisted Gait Training Device (Welwalk®) plus physiotherapy in improving the ambulatory function in sub-acute hemiplegic stroke patients: investigator- blinded, randomized controlled trial

/A0 sites26 target enrollmentApril 19, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
sub&#45
Sponsor
/A
Enrollment
26
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2018
End Date
July 31, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients or family gave written informed consents to participant in this study
  • 2\.Patients with first episode hemiplegia caused by primary supratentorial intracerebral hemorrhage or cerebral infarction
  • 3\.Patient meet the following criteria at the initial assessment:
  • •Within 90 days after onset
  • •Aged 20\-79 years
  • •Body weight is between 40\-80 kg.
  • •Functional Independence Measure (FIM) walking score ≤ 3
  • •Brunnstrom stage of lower extremity ≤ 3
  • •Able to understand the meaning of the study and follow the instruction

Exclusion Criteria

  • 1\.History of myocardial infarction
  • 2\.Symptom of angina / arrhythmia
  • 3\.Symptom of respiratory disorders
  • 4\.Muscular or other neurological disorders such as diabetic neuropathy
  • 5\.Communicable infection
  • 6\.Joint contracture / limb deformity that affects walking: range of motion of hip \< 5 degree, knee extension \< \-5 degree, ankle dorsiflexion with knee extension position \< 5 degree
  • 7\.Heterotropic ossification that restrict the range of motion of joints of lower extremities
  • 8\.Being vulnerable to fracture such as severe osteoporosis of spine, lower extremities
  • 9\.Incontinence of urine or feces
  • 10\.Poor control of hypertension: BP ≥ 180/120 mmHg

Outcomes

Primary Outcomes

Not specified

Similar Trials